Exploring Ginkgo biloba: Pharmacology, Clinical Trials, and Future Prospects

According to demographics, traditional Chinese medicine has incorporated one of the longest-lived tree species, Ginkgo biloba. In this plant bioactive compounds such as ginkgolides, terpenoids, and flavonoids have been part of modern pharmacological investigation. These components contribute to neuroprotective, anti-inflammatory, and antioxidant properties of a plant. Because of its effect on shielding the nerve cells and enhancing the circulation of blood, geopolitical <i>Ginkgo biloba</i> is taken like medicine to treat diseases like peripheral vascular disorder diseases, dementia syndrome, and Alzheimer’s disease. Recent trends in Novel Drug Delivery Systems (NDDS) of Ginkgo biloba have various advancements to enhance the efficacy of herbal remedies. The use of NDDS in herbal medicines is significant because it improves efficacy and drug delivery accuracy. Clinical studies of <i>Ginkgo biloba</i> are rather disputable. While some of the trials demonstrated minor improvements in cognitive skills and symptoms’ alleviation, others could not demonstrate noticeable differences in the efficacy of Gb versus placebo. Nevertheless, Ginkgo biloba is still used in supplement form and research is currently being carried out to determine how ginkgo works and how it might be further incorporated into treatments. More intensive clinical trials using optimised extracts, the improvement in the pharmacokinetics of <i>Ginkgo biloba</i> and possibly completely new applications such as neurodegenerative diseases and cardiovascular diseases can be part of the future of the herb. The study of the effects of Ginkgo biloba and its pharmacology has therapeutic implications; therefore, more studies may lead to an improved and evidence-based medical approach.